James Investment Research Inc Metlife Inc Transaction History

James Investment Research Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 24, 2019	SELL	$43.93 - $49.67 $2,240 - $2,533	-51 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$40.87 - $45.72 $1.07 Million - $1.2 Million	-26,219 Reduced 99.81%	51 $2,000
Q4 2018 Jan 22, 2019	SELL	$38.24 - $47.77 $669,964 - $836,930	-17,520 Reduced 40.01%	26,270 $1.08 Million
Q3 2018 Oct 26, 2018	BUY	$43.4 - $48.79 $89,838 - $100,995	2,070 Added 4.96%	43,790 $2.05 Million
Q2 2018 Jul 19, 2018	BUY	$43.6 - $48.46 $21,364 - $23,745	490 Added 1.19%	41,720 $1.82 Million
Q1 2018 Apr 12, 2018	BUY	$44.08 - $54.77 $1.82 Million - $2.26 Million	41,230 New	41,230 $1.89 Million
Q4 2017 Jan 23, 2018	SELL	$50.56 - $55.73 $1.74 Million - $1.92 Million	-34,400 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$46.68 - $51.95 $1.61 Million - $1.79 Million	34,400	34,400 $1.79 Million

1,472

490M

6.75M

10M

Ticker MET
Exchange NYSE
Sector Financial Services
Industry Insurance—Life
Shares Outstandng 797,614,016
Market Cap $65.6B
Description
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disabilit...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.